New Product Introduction 丨FZM Series Fluid-bed Granulator: New Scenarios for Drug Development

Find the latest Blogs news from Canaan
Blog - New Product Introduction 丨FZM Series Fluid-bed Granulator: New Scenarios for Drug Development
Lily

In the development of innovative drugs, process optimization of generic drugs and scientific research scenarios in universities, traditional Fluid-bed equipment faces three core challenges:

1. Insufficient batch adaptability: Conventional equipment processing capacity starts at kilograms, which cannot meet the needs of 100g-level micro-experiments, resulting in raw material waste and a surge in R&D costs;

2. Single function and space limitation: Drying, granulation, coating and other processes require multiple equipment to cooperate, laboratory space utilization is low and operation is complicated;

3. Data traceability and compliance pressure: Traditional equipment lacks refined parameter control and data recording functions, and it is difficult to meet GMP requirements for process verification and traceability.

In response to the above points, Canaan Technology launched the FZM Series Fluid-bed Granulator, with “miniaturization, modularization, and intelligence” as the core, redefining laboratory-level solid dosage development tools.


New Positioning: Ideal Solution for Small Batch R&D

1. Applicable Scenarios:

• Process exploration of high-value APIs (such as ADC drugs and peptides);

• Prescription optimization and process verification in the consistency evaluation of generic drugs;

• Innovative dosage form development in universities and research institutes (such as sustained-release pellets and orodispersible films).

2. Processing Batch: 100g-200g (micro-scale experimental requirements);

3. Functional Coverage: drying, granulation, pellet/powder/tablet coating;

4. Space Design: The size of the whole machine is adapted to the laboratory table, supporting “plug and play” deployment.

Core Advantage: Innovative Design

Feature 1: Modular Integration: Double Improvement of Space and Efficiency

• Integrated architecture: Integrates air blowing, heating, slurry addition and control systems to reduce reliance on external equipment;

• Quick switching module: The function of the Fluid-bed and coating pan can be switched through a clamp connection, and the process switching can be completed within 5 minutes (traditional equipment takes several hours);

• Convenience of mobility: The weight of the whole machine is optimized to be portable by two people, supporting flexible deployment across laboratories.

Feature 2 Multifunctional Process Platform: Seamless Connection from R&D to Pilot Production

•Full process coverage: a single device supports key processes such as drying, granulation, and coating;

•Micro-process adaptation: fluidized air duct and atomization system designed specifically for small batches, ensuring process stability as low as 100g batches.

Feature 3 Intelligent Software: Data-driven R&D Decisions

• Free parameter configuration: multiple sets of parameters can be set by yourself, covering variables such as temperature and injection rate;

• Real-time monitoring and traceability: built-in sensors can realize millisecond-level acquisition of key data (such as bed temperature and pressure gradient), in compliance with FDA 21 CFR Part 11 electronic record regulations;

• Cloud collaboration: optional data export function, directly connected to the LIMS system, to accelerate the transfer of knowledge from R&D to production.


Customer Value: From Cost Control to Compliance Upgrade

• Cost optimization: micro-scale processing reduces the loss of high-value raw materials and reduces the cost of a single experiment by 70%;

• Efficiency breakthrough: module switching and parameter preset functions shorten the process development cycle;

• Compliance guarantee: fully enclosed design + SUS316L material, meeting GMP requirements for cross-contamination prevention and control and cleaning verification.

Future trends of miniaturized equipment

With the popularization of personalized drug development and continuous manufacturing technology, laboratory equipment is accelerating its iteration towards “micro, intelligent, and compliant“. In the future, Canaan Technology will continue to deepen the process optimization algorithm enabled by AI and promote the evolution of desktop equipment from “experimental tools” to “R&D brains”.

RELATED POSTS
April 30.2025
Canaan
What Equipment Does a Pharmaceutical Lab Use?

Before any drug reaches a patient, it starts in a lab. That’s where formulas are tested, batches are checked, and quality is either confirmed or questioned. To do that work right, labs depend on the right equipment—tools that don’t just get the job done, but do it with precision.  If you’re responsible for running or […]

Read More
April 30.2025
Canaan
Blister Packaging: Methods, Components, and Advantages

Blister packaging is everywhere in pharma—from tablets to capsules to sample packs. It protects the product, extends shelf life, and improves patient safety. But for manufacturers, it’s more than just packaging—it’s a system built around speed, precision, and compliance.  If you’re in pharma manufacturing or packaging procurement, here’s what you need to know about blister […]

Read More
April 30.2025
Canaan
Softgels vs Tablets: Key Differences You Should Know

If you’re deciding how to deliver a pharmaceutical or supplement product, the format you choose—liquid gels or tablets—will shape more than just how it looks. It affects how the product is made, how fast it’s absorbed, what kind of equipment you’ll need, and how the end user experiences it. Some actives work better in a […]

Read More

Get in Touch Now